This allocation marks a crucial step in responding to the spread of the clade Ib variant, which prompted WHO to declare mpox a global public health emergency for the second time in August, following the variant’s spread from the Democratic Republic of Congo (DRC) to neighbouring nations.
The vaccine doses will target the most vulnerable populations in the Central African Republic, Ivory Coast, DRC, Kenya, Liberia, Nigeria, Rwanda, South Africa, and Uganda. The DRC, the most severely affected, will receive 85% of the total supply.
